jianqiang xu
School of Chemical Engineering, Marine and Life Sciences, Dalian University of Technology
Dalian, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
School of Chemical Engineering, Marine and Life Sciences, Dalian University of Technology
Dalian, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
Fudan University
Shanghai, China
Associate Editor
Inflammation Pharmacology
University of South Carolina
Columbia, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
University of Science and Technology of China
Hefei, China
Associate Editor
Translational Pharmacology
School of Medicine, Shanghai Jiao Tong University
Shanghai, China
Associate Editor
Pharmacology of Ion Channels and Channelopathies
National Institutes of Health (NIH)
Bethesda, United States
Associate Editor
Drug Metabolism and Transport
Rutgers Biomedical and Health Sciences, Rutgers, The State University of New Jersey
Newark, United States
Associate Editor
Neuropharmacology
Xiangya Hospital, Central South University
Changsha, China
Associate Editor
Pharmacology of Anti-Cancer Drugs
Macau University of Science and Technology
Taipa, Macao, SAR China
Associate Editor
Pharmacology of Anti-Cancer Drugs
Department of Earth Sciences, Faculty of Sciences, Mohammed V University of Rabat
Rabat, Morocco
Associate Editor
Ethnopharmacology
National Institute of Environmental Health Sciences (NIH)
Durham, United States
Associate Editor
Neuropharmacology
Hampton University
Hampton, United States
Associate Editor
Renal Pharmacology
School of Medicine, Wake Forest University
Winston-Salem, United States
Associate Editor
Neuropharmacology
Georgia Cancer Center, Augusta University
Augusta, United States
Associate Editor
Pharmacology of Anti-Cancer Drugs
Shanghai Jiao Tong University
Shanghai, China
Associate Editor
Gastrointestinal and Hepatic Pharmacology
Xiangya Hospital, Central South University
Changsha, China
Associate Editor
Pharmacology of Anti-Cancer Drugs